Total Funding
$61M
Employee Range
11-50
Kynexis is pioneering the first precision medicine aimed at treating cognitive impairment associated with schizophrenia (CIAS). By leveraging advanced research, Kynexis seeks to enhance cognitive function and improve the quality of life for individuals affected by this challenging condition.
Kynexis data powered by:
Share
Kynexis data powered by:
KynexisOverall Ranking
National Rank
Share
Loading...
In The Netherlands
Top null%out of startups
Regional Rank
Share
Loading...
In Western Europe
Top null%out of startups
KynexisIndustry Rankings in
Healthtech
City Rank
Share
2nd
In Naarden
Top 67%out of 3 startups
National Rank
Share
37th
In The Netherlands
Top 15%out of 253 startups
Regional Rank
Share
681st
In Western Europe
Top 15%out of 4548 startups
KynexisSubindustry Rankings in
BiotechnologyCity Rank
Share
2nd
In Naarden
Top 67%out of 3 startups
National Rank
Share
20th
In The Netherlands
Top 20%out of 105 startups
Regional Rank
Share
256th
In Western Europe
Top 15%out of 1726 startups
rankings by:
KynexisSB Rank Evolution
Not enough data points to display the chart.
KynexisstartupComparison
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...
See all ranked entities with a premium subscription
Get Pro